Stryker Corporation (LON:0R2S)

Market Cap	115.54B
Revenue (ttm)	18.05B
Net Income (ttm)	2.39B
Shares Out	n/a
EPS (ttm)	6.20
PE Ratio	48.33
Forward PE	n/a
Dividend	2.53 (0.66%)
Ex-Dividend Date	Mar 31, 2025

Volume	621
Average Volume	629
Open	389.12
Previous Close	386.18
Day's Range	383.67 - 389.12
52-Week Range	250.79 - 386.84
Beta	0.99
RSI	44.96
Earnings Date	Jan 28, 2025

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgi...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1941
• Employees: 53,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R2S

Financial Performance

In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.

Financial numbers in USD